BUROSUMAB (Crysvita®)

Clinical Indication

X-linked hypophosphataemia in children and young people


Not yet reviewed

Date of classification

February 2019


Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.